NRL001 not checked

Norgine · methoxamine gel 0.3% · 1.0%

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“A single application of 0.3%, 1.0%, 3.0% NRL001 gel in stepwise dose ascending fashion.”In the company’s words, NCT06593743 on ClinicalTrials.gov
Tested for
Faecal Incontinence (2 trials)
Main trialPhase 1
“Single centre dose-finding and proof-of-concept study in healthy volunteers to assess the effects of single doses of NRL001 on the mean anal resting pressure (MARP). In addition, the pharmacokinetics of NRL001 and subject safety are also examined.”In the company’s words, NCT06593743 on ClinicalTrials.gov
Other names
methoxamine gel 0.3% · 1.0% · 3.0% · methoxamine gel 3.0% · methoxamine gel 1.0% · methoxamine suppository

Other drugs for Faecal Incontinence

All 1 drugs for Faecal Incontinence

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1Completed Jul 2004 The Safety and Dose Response to Single Anal Doses of NRL001
Phase 1Completed Aug 2007 Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow NRL001

Following is part of Solo: you see every change to NRL001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in